| Literature DB >> 25863291 |
Arianna Cattelan1, Giulio Ceolotto1, Sergio Bova2, Mattia Albiero3, Maniselvan Kuppusamy1, Sara De Martin2, Andrea Semplicini1, Gian Paolo Fadini4, Saula Vigili de Kreutzenberg1, Angelo Avogaro5.
Abstract
Ischemia-reperfusion (IR) leads to severe organ injury and dysfunction. Sirtuins (SIRTs) are a family of histone deacetylases (HDACs) that require nicotinamide adenine dinucleotide (NAD(+)) for the deacetylation reaction. SIRTs play a major role in counteracting cellular stress and apoptosis. This study aimed to investigate the mechanisms of heart protection against apoptosis by SIRTs and the molecular pathways involved in SIRTs regulation and function in a rat model of IR injury. Hearts of male Wistar-Kyoto rats were subjected to 30-min ischemia followed by reperfusion up to 6h. IR increased cardiomyocyte apoptosis; the cleavage of caspase 3, induced a transient upregulation of SIRT1 and downregulation of SIRT6 expression, but decreased SIRT1 activity and reduced NAD(+) content. IR also increased forkhead box protein O1 (FoxO1) expression and FoxO1 binding to SIRT1 promoter region. Resveratrol restored SIRT1 activity and NAD(+) level by an AMPK-dependent mechanism, reduced cardiomyocyte apoptosis, and attenuated caspase 3 cleavage via heat shock factor-1 deacetylation and heat shock protein (HSP) expression upregulation. Our data show new potential molecular mechanisms of up and downstream regulation of SIRT1 in IR. The interplay among FoxO1, SIRT1, NAD(+), AMPK, HSP, and SIRT6 depicts a complex molecular network that protects the heart from apoptosis during IR and may be susceptible to therapeutic interventions.Entities:
Keywords: Apoptosis; Caspase 3; Compound C (PubChem: CID 11524144); FK-866 (PubChem: CID 6914657); NAD(+); Reperfusion injury; Resveratrol (PubChem: CID 445154); SIRTs; Sirtinol (PubChem: CID 5717148); alpha-d-Glucose (PubChem: CID 79025); d-mannitol (PubChem: CID 6251)
Mesh:
Substances:
Year: 2015 PMID: 25863291 DOI: 10.1016/j.vph.2015.02.004
Source DB: PubMed Journal: Vascul Pharmacol ISSN: 1537-1891 Impact factor: 5.773